LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 PF431396
1.11
uM
LJP5
 0.3784 0.0291 0.0982 0.0544
BT-20 PF477736
1.11
uM
LJP5
 0.9587 0.0133 0.9396 0.0200
BT-20 PF562271
1.11
uM
LJP6
 0.6654 0.0651 0.5189 0.0861
BT-20 PHA-665752
1.11
uM
LJP5
 0.9974 0.0194 0.9956 0.0282
BT-20 PHA-793887
1.11
uM
LJP6
 0.3708 0.0510 0.0910 0.0568
BT-20 PI103
1.11
uM
LJP6
 0.3656 0.0705 0.0846 0.0855
BT-20 PLX-4720
1.11
uM
LJP5
 0.9161 0.0759 0.8811 0.1068
BT-20 QL-X-138
1.11
uM
LJP6
 0.6325 0.0778 0.4720 0.1040
BT-20 QL-XII-47
1.11
uM
LJP6
 0.3510 0.0854 0.0644 0.1066
BT-20 Radicicol
1.11
uM
LJP5
 0.2978 0.0305 -0.0192 0.0635
BT-20 Radicicol
1.11
uM
LJP6
 0.3064 0.0316 -0.0068 0.0654
BT-20 Seliciclib
1.11
uM
LJP5
 0.8822 0.0431 0.8317 0.0598
BT-20 Ruxolitinib
1.11
uM
LJP5
 0.9948 0.0421 0.9924 0.0600
BT-20 XL147
1.11
uM
LJP5
 0.9874 0.0314 0.9805 0.0452
BT-20 Saracatinib
1.11
uM
LJP6
 0.8111 0.0340 0.7282 0.0446
BT-20 Selumetinib
1.11
uM
LJP6
 0.9873 0.0288 0.9817 0.0410
BT-20 Sirolimus
1.11
uM
LJP6
 0.6242 0.0248 0.4556 0.0359
BT-20 Sorafenib
1.11
uM
LJP6
 0.8596 0.0233 0.7978 0.0301
BT-20 SU11274
1.11
uM
LJP5
 0.9493 0.0062 0.9266 0.0087
BT-20 Fedratinib
1.11
uM
LJP5
 0.8662 0.0180 0.8071 0.0226
BT-20 TGX221
1.11
uM
LJP5
 1.0356 0.0295 1.0509 0.0416
BT-20 Torin1
1.11
uM
LJP6
 0.2761 0.0225 -0.0478 0.0120
BT-20 Torin2
1.11
uM
LJP5
 0.2037 0.0195 -0.1539 0.0333
BT-20 Tozasertib
1.11
uM
LJP5
 0.2940 0.0207 -0.0243 0.0509
BT-20 Trametinib
1.11
uM
LJP5
 0.7821 0.0296 0.6859 0.0372